At a FDR of 1%, APEX1 associated with dHRICA in pan-cancer, and at a FDR of 2% it associated with dHRVAE2 in pan-cancer and with APOBECVAE2 in stomach/esophagus cancer. This evidence concerns the gene APEX1 and esophageal cancer.